search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
64 HAIR CARE


NON-TREATED hair


Hair TREATED with C15-19 alkanes/hydrogenated polyfarnesene


dimethicone/dimethiconol


Hair TREATED with


Figure 2: Observation by SEM-FEG (Scanning Electron Microscopy - Field Emission Gun) of non-treated hair, hair treated with C15-19 alkanes/ hydrogenated polyfarnesene and hair treated with dimethicone/dimethiconol blend


meaning that their performance is similar. The same method was then used to assess the performance of both products in a leave-on hair serum formulation. The first test condition is to treat the hair tress with the placebo serum and to expose it to thermal stress. The second and third conditions are to treat


the hair tresses with the placebo formulation containing, in addition, either 3% DMD or 3% C15-19 alkanes/hydrogenated polyfarnesene, and to expose them to thermal stress. Results can be observed in Figure 4. The tresses having been treated have


a higher k-index and a significant gain of +22% thermal protective effect on the keratin inner structure against heat damages is observed versus placebo. Once again, there are no significant differences between both treatments, meaning that the performance of DMD and C15-19 alkanes/hydrogenated polyfarnesene is comparable.


Sensoriality To compare the sensoriality performance of DMD and C15-19 alkanes/hydrogenated polyfarnesene, a triangle test was performed by an expert panel. The principle of this triangle test is to present in a random arrangement three pre-treated tresses to the panelists.


Among these samples, two are identical


1.0 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1


HEALTHY keratin


NO thermal treatment


DAMAGED keratin


THERMAL TREATMENT without product


PRESERVED keratin with both tested products


polyfarnesene (pure)


+ C15-19 alkanes/ hydrogenated


THERMAL TREATMENT


dimethiconol blend (pure)


Figure 3: Keratin visualization through polarimetric imaging method PERSONAL CARE September 2022


TREATMENT+ dimethiconol/


THERMAL


& the third is different. Subjects are asked to identify the tress that is different from the two others by evaluating different sensory parameters: ease of combing, glossy effect, volume control, gliding effect, greasy sensation and presence of the product (film deposit, product feel). They can also comment on the sensory of each tress. The test was realized on damaged


Caucasian hair tresses, treated with a rinse-off hair mask containing either 3% DMD or 3% C15- 19 alkanes/hydrogenated polyfarnesene. No significant difference was observed between the three tresses. DMD and C15-19 alkanes/ hydrogenated polyfarnesene present therefore a similar sensory profile, based on the studied descriptors. Once again, the product C15-19 alkanes/


hydrogenated polyfarnesene represents a sustainable alternative to classical dimethiconol blends offering the same level of performance.


Volume control & curl definition Following the good results obtained to previous testings, further investigations were made. The evaluation of the volume control and curl definition effect was interesting to perform and gave the opportunity to test the performance of C15-19 alkanes/hydrogenated polyfarnesene on a different hair type. Indeed, natural Brazilian tresses were used and treated with a leave-on serum. Besides


1.0 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1


HEALTHY keratin (negative control)


NO thermal treatment


DAMAGED keratin THERMAL


TREATMENT + placebo (serum formulation)


PRESERVED keratin with both tested products


THERMAL TREATMENT + 3% of C15-19


alkanes/hydrogenated polyfarnesene in a serum formulation


TREATMENT +3% of dimethiconol/ dimethiconol in a serum formulation


Figure 4: Keratin visualization through polarimetric imaging method www.personalcaremagazine.com THERMAL


the untreated hair tress (A), the first test condition (B) was to treat a hair tress with the placebo serum. The second (C) and third conditions (D) were to treat the hair tresses with the placebo formulation containing respectively, in addition, either 3% C15-19 alkanes/hydrogenated polyfarnesene or 3% cyclopentasiloxane/dimethiconol (CXD). The formula was applied once on wet hair


and the tresses were then dried in a climatic chamber under controlled temperature & humidity conditions at 20°C & 50% HR during six hours. The evaluation of volume control and curl definition is followed visually at the application of the formula, after four hours and up to six hours. The results can be observed in Figure 5. The non-treated condition (A) came back to


its natural look after four hours. A volume control and curl definition effect are observed on the three other conditions after four and six hours. However, the performance is better


after four hours for the C15-19 alkanes/ hydrogenated polyfarnesene treated tress, and is even more important and visible after six hours. For the volume control claim, C15- 19 alkanes/hydrogenated polyfarnesene is therefore, not only a sustainable alternative to CXD, but also a more performant solution.


Conclusion Hydogenated polyfarnesene, combined


k-index


k-index


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104